Finance

Lists
Why is TBIO up 263,64%?
Dive Deeper
TBIO:OTCMKTS
Telesis Bio Inc
USD 0,040
+263,64%
(+0,029) 1D
14 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TBIO...
Open
USD 0,01
High
USD 0,04
Low
USD 0,01
Mkt. cap
78,12 k
Avg. vol.
487,00
Volume
405,00
52-wk high
USD 0,15
52-wk low
USD 0,00
Beta
-0,52
Shares outstanding
1,78 m
No. of employees
39
Open
USD 0,01
High
USD 0,04
Low
USD 0,01
Mkt. cap
78,12 k
Avg. vol.
487,00
Volume
405,00
52-wk high
USD 0,15
52-wk low
USD 0,00
Beta
-0,52
Shares outstanding
1,78 m
No. of employees
39
News stories
From web sources and news partners
About Telesis Bio Inc
CEO-
Employees39
Founded2011
Headquarters-
SectorHealth care
Websitetelesisbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2023
Mrt. 2024
Jun. 2024
Sep. 2024
Revenue
6,98 m
3,44 m
1,55 m
1,57 m
Cost of goods sold
-
-
-
557,00 k
Cost of revenue
-
-
-
557,00 k
Research and development expenses
-
-
-
2,17 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
3,98 m
Operating expense
-
-
-
6,15 m
Total operating expenses
-
-
-
6,71 m
Operating income
-
-
-
-5,14 m
Other non operating income
-
-
-
-72,00 k
EBT including unusual items
-
-
-
-6,18 m
EBT excluding unusual items
-
-
-
-5,36 m
Income tax expense
-
-
-
1,00 k
Effective tax rate
-
-
-
-0,02%
Other operating expenses
-
-
-
-
Net income
-
-
-
-6,64 m
Net profit margin
-
-
-
-424,14%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
78,00 k
Interest expense
-
-
-
-219,00 k
Net interest expenses
-
-
-
-141,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-4,68 m
Gain or loss from assets sale
-
-
-
-173,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme